Search Results

February 2022 "Switzerland Today, InterAx Biotech is pleased to announce that Carola Weiss has joined Carola Weiss is a Senior Executive with more than 20 years of international experience in the biopharmaceutical

February 2022 "InterAx Biotech AG and Boehringer Ingelheim take first steps towards collaborating to unlock orphan targets leveraging InterAx AI driven discovery platform. first-in-class small molecule agonists for a challenging orphan GPCR for a highly relevant therapeutic need. 💊 InterAx Biotech AG discovery platform was already successfully applied in projects with biopharmaceutical companies #ai #biotech #systemsbiology #drugdiscovery #gpcr #deeptech #orphandrugs #pharma #partnerships #AI4drugdiscovery

at the GPCR-Targeted Drug Discovery Summit 2026 The meeting brings together 80+ senior leaders from biotech Sessions from InterAx Biotech, Northeastern University, and Function Therapeutics dig into this — moving Companies presenting include Skymab Biotherapeutics, Confo Therapeutics, GSK, Metaphore Biotechnologies Chris Dockendorff is the founder of Function Therapeutics, a small biotech on the University of Wisconsin–Milwaukee

Maria Waldhoer, CSO of InterAx Biotech AG, argues that endpoint assays — the field's default way of characterizing Maria Waldhoer is Chief Scientific Officer at InterAx Biotech AG in Switzerland. Maria Waldhoer, CSO of InterAx Biotech 02:19 — From zoology to GPCRs: fate, not choice 06:48 — Academia Biotech in Switzerland as their Chief Scientific Officer. Maria Waldhoer on the web LinkedIn InterAx Biotech Pubmed Dr.

He is Chief Scientific Officer and co-founder of InterAx Biotech, where he specializes in the development Aurélien Rizk on the web InterAx Biotech Paul Scherrer Institut The Org LinkedIn Google Scholar Dr. They wrapped up the conversation by discussing job opportunities at Interax Biotech and their anticipation Aurelien Rizk, a co-founder and CEO of Interax Biotech, shared about the company's development of a discovery The discussion concluded with a brief overview of job opportunities at Interax Biotech, with Aurelien

Panelists from InterAx Biotech, Rockefeller University, and the University of New Mexico — computational Maria Waldhoer is Chief Scientific Officer at InterAx Biotech in Switzerland. Aurélien Rizk is Chief Technology Officer at InterAx Biotech. Yaroslav Nikolaev is a scientist at InterAx Biotech with a dual background in biology and computation Selected Quotes "My computational team told me, 'this receptor is not using arrestin to internalize.